T H Brannagan Selected Research

Antisense Oligonucleotides

1/2020

Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T H Brannagan Research Topics

Disease

3	Polyneuropathies (Polyneuropathy) 01/2020 - 06/2002
3	Celiac Disease (Celiac Sprue) 12/2008 - 05/2003
2	Paraproteinemias (Monoclonal Gammopathy) 02/2008 - 08/2006
1	Disease Progression 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Amyloidosis 01/2020
1	Transthyretin-Related Hereditary Amyloidosis 01/2020
1	Small Fiber Neuropathy 12/2008
1	Ataxia (Dyssynergia) 12/2008
1	Cerebellar Ataxia (Dysmetria) 12/2008
1	Cerebellar Diseases (Cerebellar Syndrome) 12/2008
1	Neuralgia (Stump Neuralgia) 12/2008
1	Infections 02/2008
1	Hepatitis C 02/2008
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 08/2006
1	Myasthenia Gravis 05/2004
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 06/2002

Drug/Important Bio-Agent (IBA)

2	Glucose (Dextrose)FDA LinkGeneric 02/2008 - 08/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2004 - 06/2002
1	InotersenIBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Antisense OligonucleotidesIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Prealbumin (Transthyretin)IBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2008
1	sulfate-3-glucuronyl paraglobosideIBA 08/2007
1	Glutens (Glutelin)IBA 05/2003

Therapy/Procedure

1	Gluten-Free Diet 12/2008
1	Therapeutics 06/2002